1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Receives “Neutral” Rating from Cantor FitzgeraldMarketBeat X
1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $1,080.00 at BarclaysMarketBeat X
1 month Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech InnovationInsider Monkey X
1 month The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and BiogenZacks X
1 month Sequoia Financial Advisors LLC Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)MarketBeat X
1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $1,050.00 by Analysts at Wells Fargo & CompanyMarketBeat X
1 month BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 4.7% – Here’s What HappenedMarketBeat X
1 month Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High – Here’s What HappenedMarketBeat X
1 month Regeneron Pharmaceuticals (NASDAQ:REGN) Earns “Outperform” Rating from Royal Bank of CanadaMarketBeat X
1 month Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat X
1 month Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Rating of “Moderate Buy” by BrokeragesMarketBeat X
1 month Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What HappenedMarketBeat X
1 month Creative Planning Purchases 2,178 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)MarketBeat X
1 month Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat X
1 month Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume – Should You Buy?MarketBeat X
1 month 50,500 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Purchased by Toth Financial Advisory CorpMarketBeat X
Stock Market News